The partnership between the Garvan Institute of Medical Research and the Weizmann Institute of Science is a collaborative international endeavour that harnesses the synergistic  strengths  of two world-class  research institutes.

Through joint programs and cutting-edge technologies, Garvan and Weizmann are together uncovering entirely new insights into cancer, immune diseases, metabolic disorders and other conditions.

Weizmann Institute of Science

The Weizmann Institute of Science (Rehovot, Israel) is one of the world’s leading multidisciplinary basic research institutions in the natural sciences. The Weizmann Institute has a long history of investigation and discovery rooted in a mission of advancing science for the benefit of humanity. In parallel, it educates a substantial proportion of Israel’s scientific leadership and advances science literacy in schools and among the public. It comprises 250 experimental and theoretical research groups across five faculties – Biology, Biochemistry, Chemistry, Mathematics and Computer Science, and Physics.

Kinghorn Centre for Clinical Genomics

In 2012, Garvan established the Kinghorn Centre for Clinical Genomics, Australia's first purpose-built facility for undertaking clinical-grade genome sequencing. In 2016, Garvan launched Genome.One, Australia's first clinical whole-genome sequencing service.